Name | sodium,(2R)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate |
---|---|
Synonyms |
Sodium (2R)-2-[6-(4-chlorophenoxy)hexyl]-2-oxiranecarboxylate
2-Oxiranecarboxylic acid, 2-[6-(4-chlorophenoxy)hexyl]-, sodium salt, (2R)- (1:1) cc-140 (+)-Etomoxir (sodium salt) ANTI-EAPII(TTRAP) (2R)-2-[6-(4-Chlorophenoxy)hexyl]oxiranecarboxylic acid sodium salt MFCD07787411 (+)-Etomoxir sodium salt (R)-(+)-Etomoxir (sodium salt) |
Description | (R)-Etomoxir sodium salt is the R-form of Etomoxir sodium salt, acts as an inhibitorof carnitine palmitoyltransferase I (CPT-I), and inhibits palmitate β-oxidation in human, rat and guinea pig. |
---|---|
Related Catalog | |
Target |
CPT-1[1] |
In Vitro | (R)-Etomoxir sodium salt is the R-form of Etomoxir sodium salt, acts as an inhibitorof carnitine palmitoyltransferase I (CPT-I), and inhibits palmitate β-oxidation in human, rat and guinea pig[1]. |
References |
Molecular Formula | C15H18ClNaO4 |
---|---|
Molecular Weight | 320.744 |
Exact Mass | 320.079132 |
PSA | 61.89000 |
LogP | 2.18820 |
Storage condition | -20℃ |
Hazard Codes | Xn: Harmful; |
---|---|
Risk Phrases | 22 |
RIDADR | UN 2811 6.1/PG 3 |